Gene and Cell Therapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section of Biomedicines aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage the submission of manuscripts that provide novel and mechanistic insights and papers that report significant advances on the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Engineering Extracellular Matrix (ECM)-Based Scaffold Biomaterials for Cancer Treatment (Deadline: 31 August 2026)
- Skin Diseases and Cell Therapy (Deadline: 30 September 2026)
- Fertility and Reproductive Health: Understanding of Reproductive Physiology and Pathology (Deadline: 31 October 2026)
- Next-Generation CRISPR and Immune Modulation: Advancing Precision Genome Editing Therapies for Genetic Disorders (Deadline: 31 October 2026)
- Cell-Based Immunotherapy: CAR-T Cells, CAR-NK and TCR-Engineered Cells (Deadline: 31 October 2026)
- Cell-Based Immunotherapies: CAR-T, CAR-NK and TCR-Engineered Cells (Deadline: 31 October 2026)
- Gene Therapy for Human Diseases: From Bench to Bedside (Deadline: 31 December 2026)
- Innovative Therapies for Neurodegenerative Diseases (Deadline: 10 January 2027)
- Genomic Technologies: Polymorphisms as Potential Biomarkers (Deadline: 31 March 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
